ArticleNeuro-oncology advances

A phase 1 trial of iron metabolism-targeting oral gallium maltolate in recurrent and refractory glioblastoma.

Jennifer M Connelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.